UNSPSC 51123203: Aprindine hydrochloride

This classification denotes an antiarrhythmic agent with the molecular formula C22H30N2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PB5EKT7Q2V, chemically known as 1,3-propanediamine, n-(2, 3-dihydro-1h-inden-2-yl)-n,n-diethyl-n-phenyl-, monohydrochloride but more generally known as aprindine hydrochloride, which bears US NIH Compound Identifier 2218. European Medicines Agency schedules Aprindine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00565MIG.

UNSPSC 51123203 Aprindine hydrochloride is a Commodity code for a specific cardiac antiarrhythmic medication, though state and local procurement activity under this code shows limited recent volume. The single recent opportunity in the data reflects the actual demand for advanced life support medications more broadly — Tampa Fire Rescue's procurement of epinephrine, labetalol, adenosine, and diltiazem for emergency medical use — rather than procurement specifically targeting aprindine. Fire rescue departments and municipal emergency services are the primary end-users of medications classified under this code tier, acquiring them through city purchasing departments and procurement offices.

The City of Tampa's Purchasing Department posted Bid No. 26-P-00188 on April 24, 2026, with a response deadline of April 8, 2026, for advanced life support medications estimated at $40,000.00 for one-year delivery with options to renew. The bid carried a Small Local Business Enterprise (SLBE) sheltered market designation with a 5 percent discount capped at $10,000, required Safety Data Sheets compliant with OSHA Hazard Communication Standards, and mandated accessibility documentation to WCAG 2.2 Level AA and Section 508 standards. Florida represents the only state with recent documented activity under this code; broader geographic activity cannot be characterized from available records.